-
FDA authorizes a new liver safety biomarker relevant for Duchenne and Becker
We congratulate C-PATH (Critical Path Institute) on their success in getting the FDA to qualify […]
-
FDA approves new safety warning and updated prescribing information for Sarepta’s Elevidys
The FDA has approved the new labeling information Sarepta provided for Elevidys, Sarepta’s gene therapy […]








